HUMHUMANA INC

NYSE humana.com


$ 305.99 $ -5.51 (-1.77 %)    

Friday, 26-Apr-2024 15:59:54 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 305.9
$ 309.16
$ 0.00 x 0
$ 0.00 x 0
$ 305.86 - $ 310.50
$ 299.23 - $ 536.74
1,213,131
na
36.86B
$ 0.91
$ 18.51
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-24-2024 03-31-2024 10-Q
2 02-15-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 04-26-2023 03-31-2023 10-Q
6 02-16-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 07-27-2022 06-30-2022 10-Q
9 04-27-2022 03-31-2022 10-Q
10 02-17-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 04-28-2021 03-31-2021 10-Q
14 02-18-2021 12-31-2020 10-K
15 11-03-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 04-29-2020 03-31-2020 10-Q
18 02-20-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 07-31-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 02-21-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-16-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 02-17-2017 12-31-2016 10-K
31 11-04-2016 09-30-2016 10-Q
32 08-03-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 02-18-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 07-29-2015 06-30-2015 10-Q
37 04-29-2015 03-31-2015 10-Q
38 02-18-2015 12-31-2014 10-K
39 11-07-2014 09-30-2014 10-Q
40 07-30-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports-this-week

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...

 rbc-capital-maintains-outperform-on-humana-lowers-price-target-to-353

RBC Capital analyst Frank Morgan maintains Humana (NYSE:HUM) with a Outperform and lowers the price target from $415 to $353.

 ubs-maintains-neutral-on-humana-lowers-price-target-to-326

UBS analyst Kevin Caliendo maintains Humana (NYSE:HUM) with a Neutral and lowers the price target from $334 to $326.

 cantor-fitzgerald-maintains-neutral-on-humana-lowers-price-target-to-360

Cantor Fitzgerald analyst Sarah James maintains Humana (NYSE:HUM) with a Neutral and lowers the price target from $391 to $360.

 oppenheimer-maintains-outperform-on-humana-lowers-price-target-to-370

Oppenheimer analyst Michael Wiederhorn maintains Humana (NYSE:HUM) with a Outperform and lowers the price target from $415 t...

 humana-withdraws-its-already-lowered-2025-profit-guidance

Humana revises 2025 profit forecast due to disappointing Medicare Advantage reimbursement rates. Medical benefit ratio up to 88...

 treasury-yields-rise-tesla-jumps-on-cheaper-model-pledge-yen-plummets-to-34-year-lows-whats-driving-markets-wednesday

Rising Treasury yields have investors cautious despite positive news from the earnings season. The yield on the long-dated 3...

 humana-earlier-said-our-2025-adj-eps-growth-outlook-will-be-impacted-by-several-variables-to-which-we-will-not-have-clear-visibility-until-later-this-year-we-believe-it-is-prudent-to-provide-more-specific-guidance-for-2025-once-we-have-greater-clarity-we-no-longer-believe-6-to-10-of-adj-eps-growth-is-the-appropriate-target-range-for-2025

- Conf Call

 humana-boosts-medicare-advantage-membership-2024-forecast-as-q1-earnings-performance-exceeds-expectations

Humana reports Q1 adjusted EPS of $7.23, surpassing expectations. Revenues rise to $29.33 billion driven by Medicare premiums a...

 nasdaq-futures-get-a-lift-from-tesla-texas-instruments-earnings-analyst-points-to-key-catalyst-for-boosting-rally

Nasdaq and S&P 500 futures signaled a higher open on Wednesday, thanks to upbeat guidance from EV giant Tesla, Inc. (NASDAQ...

 humana-affirms-fy24-adjusted-eps-outlook-of-approximately-1600-est-1636

Revises FY 2024 EPS guidance to 'approximately $13.93' (previously 'approximately $14.87') on a GAAP basis

 humana-q1-2024-adj-eps-723-beats-612-estimate-adj-sales-29332b-beat-28473b-estimate

Humana (NYSE:HUM) reported quarterly Adj earnings of $7.23 per share which beat the analyst consensus estimate of $6.12 by 18.1...

 jefferies-maintains-buy-on-humana-lowers-price-target-to-381

Jefferies analyst David Windley maintains Humana (NYSE:HUM) with a Buy and lowers the price target from $411 to $381.

 can-magnificent-7-help-script-market-turnaround-earnings-pick-up-pace-with-microsoft-meta-alphabet-and-tesla-expected-this-week

Corporate profit growth rose in Q3 2023 and is expected to continue in Q1.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION